Taylor-Papadimitriou J - Search Results

1

Beatson RE, Taylor-Papadimitriou J, Burchell JM. Beatson RE, et al. Immunotherapy. 2010 May;2(3):305-27. doi: 10.2217/imt.10.17. Immunotherapy. 2010. PMID: 20635898 Review.

2

Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.

Heukamp LC, van Hall T, Ossendorp F, Burchell JM, Melief CJ, Taylor-Papadimitriou J, Offringa R. Heukamp LC, et al. J Immunother. 2002 Jan-Feb;25(1):46-56. doi: 10.1097/00002371-200201000-00005. J Immunother. 2002. PMID: 11926165

3

MUC1 and the immunobiology of cancer.

Taylor-Papadimitriou J, Burchell JM, Plunkett T, Graham R, Correa I, Miles D, Smith M. Taylor-Papadimitriou J, et al. J Mammary Gland Biol Neoplasia. 2002 Apr;7(2):209-21. doi: 10.1023/a:1020360121451. J Mammary Gland Biol Neoplasia. 2002. PMID: 12463741 Review.

4

Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Correa I, Plunkett T, Vlad A, Mungul A, Candelora-Kettel J, Burchell JM, Taylor-Papadimitriou J, Finn OJ. Correa I, et al. Immunology. 2003 Jan;108(1):32-41. doi: 10.1046/j.1365-2567.2003.01562.x. Immunology. 2003. PMID: 12519300 Free PMC article.

5

Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.

Mungul A, Cooper L, Brockhausen I, Ryder K, Mandel U, Clausen H, Rughetti A, Miles DW, Taylor-Papadimitriou J, Burchell JM. Mungul A, et al. Int J Oncol. 2004 Oct;25(4):937-43. Int J Oncol. 2004. PMID: 15375543

6

Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor.

Wilkie S, Picco G, Foster J, Davies DM, Julien S, Cooper L, Arif S, Mather SJ, Taylor-Papadimitriou J, Burchell JM, Maher J. Wilkie S, et al. J Immunol. 2008 Apr 1;180(7):4901-9. doi: 10.4049/jimmunol.180.7.4901. J Immunol. 2008. PMID: 18354214

7

Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas.

Picco G, Beatson R, Taylor-Papadimitriou J, Burchell JM. Picco G, et al. Eur J Immunol. 2014 Jul;44(7):1947-55. doi: 10.1002/eji.201344076. Epub 2014 Apr 17. Eur J Immunol. 2014. PMID: 24648154 Free PMC article.

8

The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.

Beatson R, Maurstad G, Picco G, Arulappu A, Coleman J, Wandell HH, Clausen H, Mandel U, Taylor-Papadimitriou J, Sletmoen M, Burchell JM. Beatson R, et al. PLoS One. 2015 May 7;10(5):e0125994. doi: 10.1371/journal.pone.0125994. eCollection 2015. PLoS One. 2015. PMID: 25951175 Free PMC article.

9

The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.

Beatson R, Tajadura-Ortega V, Achkova D, Picco G, Tsourouktsoglou TD, Klausing S, Hillier M, Maher J, Noll T, Crocker PR, Taylor-Papadimitriou J, Burchell JM. Beatson R, et al. Among authors: taylor papadimitriou j. Nat Immunol. 2016 Nov;17(11):1273-1281. doi: 10.1038/ni.3552. Epub 2016 Sep 5. Nat Immunol. 2016. PMID: 27595232 Free PMC article.

10

Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells.

Maher J, Wilkie S, Davies DM, Arif S, Picco G, Julien S, Foster J, Burchell J, Taylor-Papadimitriou J. Maher J, et al. Among authors: taylor papadimitriou j. Immunity. 2016 Nov 15;45(5):945-946. doi: 10.1016/j.immuni.2016.10.014. Immunity. 2016. PMID: 27851917 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters